Pathways modulating glucose homeostasis independently of insulin would open new avenues to 28 combat insulin resistance and diabetes. Here, we report the establishment, characterization 29 and employment of a vertebrate 'insulin-free' model to identify insulin-independent modulators 30 of glucose metabolism. insulin knockout zebrafish recapitulate core characteristics of diabetes 31 and survive only up to larval stages. Utilizing a highly efficient endoderm transplant technique, 32 we generated viable chimeric adults that provide the large numbers of insulin mutant larvae 33 required for our screening platform. Using glucose as a disease-relevant readout, we screened 34 2233 molecules and identified 3 that consistently reduced glucose levels in insulin mutants. 35 Most significantly, we uncovered an insulin-independent beneficial role for androgen receptor 36 antagonism in hyperglycemia, mostly by reducing fasting glucose levels. Our study proposes 37 therapeutic roles for androgen signaling in diabetes and, more broadly, offers a novel in vivo 38 model for rapid screening and decoupling of insulin-dependent and -independent mechanisms. 39 40
Introduction
Characterized by the inability to control blood glucose levels, diabetes is a metabolic disease of 42 major socio-economic concern. Blood glucose levels are regulated by multiple tissues including 43 the pancreas, muscle, liver, adipocytes, gut and kidney (DeFronzo, 2009 ). Signals from 44 endocrine hormones are integrated at each tissue to effectively maintain glucose homeostasis, 45 and aberrations in this interplay underlie the pathogenesis of diabetes. Currently, seven classes 46 of antidiabetic drugs exist, of which only three function without increasing circulating insulin 47 levels and only one that definitively functions independently of insulin (Chaudhury et al., 2017) . 48 Restoring normoglycemia independently of insulin secretion or action could delay disease 49 progression as an improved glycemic status can restore -cell mass and function (Wang et al., 50 2014). Lower dependence on insulin-stimulating therapies can also prevent hyperinsulinemia-51 driven insulin resistance (Shanik et al., 2008) and obesity (Mehran et al., 2012) . In contrast to 52 insulin stimulators, Biguanides (E.g.: Metformin) and Thiazolidinediones (E.g.: Pioglitazone) are 53 effective antidiabetic agents that primarily sensitize tissues to insulin (reviewed by (Soccio et al., 54 2014; Rena et al., 2017) ). Likewise, sodium-glucose transporter 2 inhibitors (E.g.: Dapagliflozin) 55 have a complementary mechanism of reducing glucose reabsorption in the kidney (Bailey et al., 56 2013). Increasing evidence points to additional molecular pathways that can improve metabolic 57 homeostasis independently of insulin, for instance, using leptin therapy (Neumann et al., 2016) 58 or during exercise (Stanford & Goodyear, 2014) . Interestingly, currently prescribed drugs were 59 discovered from their historical use in herbal medicine (Ehrenkranz et al., 2004; Bailey, 2017) or 60 from screens directed against hyperlipidemia (Fujita et al., 1983) . However, so far, an unbiased 61 search for insulin-independent pathways controlling glucose homeostasis has remained elusive, 62 primarily due to the lack of a disease-relevant animal model for rapid screening. Due to its high 63 fecundity and amenability to chemical screening, the zebrafish serves as an excellent platform 64 to study diabetes, and it has been successfully used to study -cell mass and activity, as well as 
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insulin is crucial for zebrafish metabolic homeostasis 72 Insulin plays a central role in glucose homeostasis by increasing glucose uptake in peripheral 73 tissues, promoting glycogenesis in the liver and decreasing glucose production by inhibiting 74 glucagon secretion (Aronoff et al., 2004) . We generated zebrafish devoid of insulin signaling 75 and determined the degree to which these mutants recapitulate core features of diabetic 76 metabolism observed in mammals. The zebrafish genome contains two insulin genes -insulin 77 (ins) and insulinb (insb). Using CRISPR/Cas9 mutagenesis, we generated a 16 bp deletion allele 78 for ins ( Figure 1A ) and a 10 bp insertion allele for insb. Although ins and insb mutant embryos Figure 1D ), suggesting defects in lipid absorption and processing. Due to a combination of 85 these metabolic defects, ins mutants do not survive beyond 12 dpf ( Figure 1E ). Moreover, oxidative phosphorylation, which were affected in diabetic conditions across these studies, 103 were also similarly disrupted in zebrafish ins mutants (Supplementary file 1). Together, these 104 findings indicate that zebrafish ins is crucial for metabolic homeostasis and survival and that its 105 absence recapitulates core features of diabetic metabolism already at larval stages. With the ability to obtain large numbers of ins mutant embryos, we next aimed to analyze the 127 effect of known glucose homeostasis modulators and also to screen for novel ones. We tested 128 the effects of molecules that have been proposed to exert insulin-independent modulation of 129 glucose homeostasis, amongst other effects. Anti-diabetics such as Metformin, Pioglitazone and 130 Dapagliflozin, as well as the Lyn kinase activator MLR1023 (Saporito et al., 2012), were tested. 131 We also tested Fraxidin, identified in a screen for molecules that increase glucose uptake in 132 zebrafish (Lee et al., 2013) . Surprisingly, Metformin and MLR1023 exhibited no glucose-133 lowering effect in ins mutants suggesting that they act more as sensitizers of insulin signaling 134 rather than acting independently of insulin. On the other hand, Pioglitazone, Dapagliflozin and 135 Fraxidin reduced glucose levels by 11, 12 and 5% respectively ( Figure 3A ), thus attributing part 136 of their glucose lowering effect to an insulin-independent mechanism. Based on these data, we 137 decided to screen chemical libraries using our model to identify molecules that could reduce 138 glucose levels by more than 10%. To rapidly measure glucose levels in a 96-well plate format, 139 we adapted a glucose measuring kit to be sensitive to endogenous changes in larval glucose 278 Larvae were collected at 120 hpf and fixed with 4% paraformaldehyde in PBS overnight at 4 °C. 279 In situ hybridization was performed as described previously (Thisse & Thisse, 2008) . ar over solvent A (5% acetonitrile, 1% formic acid) from 5% to 30% over 215 min, from 30% to 60%, 359 from 60% to 95% and from 95% to 5% for 5 min each, followed by re-equilibration with 5% of 28.0313 and 36.0757 Da for the light and heavy labels, respectively. Peptides with a minimum 378 of seven amino acids were included in the analysis. MaxQuant was set to filter for 1% false 379 discovery rate on the peptide and protein levels, both. Only proteins with at least two peptides 380 and one unique peptide were considered identified and included in further data analysis. 381 Canonical Pathway Analysis was performed using Ingenuity Pathway Analysis (IPA) (Qiagen). 382 Differentially expressed proteins from our study (log2FC+-1.5) and from previously published 383 datasets were subjected to a Comparison Analysis in IPA. P-value maximum cut-off was set at 384 0.05 and the processes are listed according to those affected across the most studies. 
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